The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 58 | 14.8x | 20.1x | Near average | |
Growth | 36 | 6.0% | 5.6% | Near average | |
Quality | 54 | 13.3% | 7.6% | Near average | |
Safety | 46 | 1.7x | 0.4x | Near average | |
Capital Return | 22 | 0.23% | 2.19% | Below average | |
Momentum | 23 | — | — | Below average | |
Sentiment | 45 | — | — | Near average |
GE HealthCare Technologies Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy GE HealthCare Technologies Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Analysts' outlook for GEHC has seen a notable decline over the past 30 days, with the average target price dropping by 7.69% to reach $84 from $91. This decline coincided with an increase in the number of analysts covering the stock, suggesting that new opinions were more conservative or negative toward the previous valuation, especially with Goldman Sachs downgrading the stock from 'Buy' to 'Neutral'.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.